Cargando…
Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer
BACKGROUND: In the biopharmaceutical industry, biomarkers define molecular taxonomies of patients and diseases and serve as surrogate endpoints in early-phase drug trials. Molecular biomarkers can be much more sensitive than traditional lab tests. Discriminating disease biomarkers by traditional met...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028860/ https://www.ncbi.nlm.nih.gov/pubmed/24565027 http://dx.doi.org/10.1186/1752-0509-7-S5-S8 |